Skip to content

HLA Matching - Unrelated Umbilical Cord Blood Transplantation

Impact of HLA Matching on Outcome in Pediatric Patients Undergoing Unrelated Umbilical Cord Blood Transplantation.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00179946
Enrollment
30
Registered
2005-09-16
Start date
2003-06-30
Completion date
2006-04-30
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Diseases

Brief summary

The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.

Detailed description

The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation. The study will answer the following questions: 1. Is HLA matching beneficial to unrelated UCB transplantation? 2. Which HLA loci, HLA-A, B, C, DRB1, or BQB1 is/are important to math, or alternatively to mismatch, to improve graft survival? 3. Which HLA loci, HLA-A, B, C, DRB1, or BQB1 mismatches is/are permissive mismatches or well tolerated mismatches? 4. What level of typing resolution (low, intermediate, or hgh) is required to perform patient/donor H:A matching? By studying the cells and blood of donors and recipients, we may learn more about improving the tissue matching between unrelated donors and their recipients. Also, we hope to learn if an additional level of matching testing improves the results of the transplant treatment. Increasing knowledge about tissue matching could result in the improved long-term survival of cord blood transplant recipients.

Interventions

PROCEDUREHLA typing

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Pediatric Patients undergoing an unrelated umbilical cord blood transplantation.

Exclusion criteria

* Refusal to participate in study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026